Patient perceptions of breast biopsy procedures for screen-detected lesions

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 4, 2004, Pages 1063-1069

  Geller, Berta M ^a   Oppenheimer, Robert G ^b   Mickey, Ruth M ^c   Worden, John K ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

^c Office of Health Promotion Research ^*  (United States)

Author keywords

Biopsy; Breast cancer; Decision making; Needle biopsy; Side effects

Indexed keywords

ADULT; BIOPSY TECHNIQUE; BREAST BIOPSY; BREAST LESION; DECISION MAKING; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN TISSUE; INFORMED CONSENT; INTERVIEW; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL RESEARCH; PERCEPTION; PHYSICIAN; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SCREENING; STATISTICS; UNITED STATES; WORK;

EID: 2342431417     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2003.10.708     Document Type: Article

References (18)

1. Burns PR. Image-guided breast biopsy. Am J Surg 1997;193:9-11.
2. Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology 1993;188:453-5.
3. Nguyen M, McCombs MM, Ghandehari S, Kim A, Wang H, Barsky SH, et al. An update on core needle biopsy for radiologically detected breast lesion. Cancer 1996;78:2340-5.
4. Burkhardt JH, Sunshine JH. Core-needle and surgical breast biopsy: comparison of three methods of assessing cost. Radiology 1999;212:181-8.
5. Hilner BE, Bear HD, Fajardo LL. Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model. Acad Radiol 1996;3:351-60.
6. Newman J. Role of stereotactic breast biopsy in diagnosing breast cancer. Radiol Technol 1996;68:131-48.
7. Yim JH, Barton P, Weber B, Radford D, Levy J, Monsees B, et al. Mammographically detected breast cancer: benefits of stereotactic core versus wire localization biopsy. Ann Surg 1996;223:688-700.
8. Pijnappel RM, van Dalen A, Rinkes IHMB, van den Tweel JG, Mali WPTM. The diagnostic accuracy of core biopsy in palpable and non-palpable breast lesions. Eur J Radiol 1997;24:120-3.
9. Allen MJ, Thompson WD, Stuart RC, Gill PT, Walton EW, Karczenski K, et al. Management of non-palpable breast lesions detected mammographically. Br J Surg 1994;81:543-5.
10. March DE, Raslavicus A, Coughlin BF, Klein SV, Makari-Judson G. Use of breast core biopsy in the United States: results of a national survey. AJR Am J Roentgenol 1997;169:697-701.
11. Soo MS. Imaging-guided core biopsies in the breast. South Med J 1998;91:994-1000.
12. Liberman L, Feng T, Dershaw D, Morris E, Abramson A. US-guided core breast biopsy: use and cost-effectiveness. Radiology 1998;208:717-23.
13. Handy RB, Fajardo LL, Innis CA, Witzke DB, Hunter TB. Patient perceptions of stereotaxis large-core breast biopsy. Acad Radiol 1996;3:1001-7.
14. Frazee RC, Roberts JW, Symmonds RE, Snyder SK, Hendricks JC, Smith RW, et al. Open versus stereotactic breast biopsy. Am J Surg 1996;172:485-91.
15. Philpotts LE, Hooley RJ, Lee CH. Comparison of automated versus vacuum-assisted biopsy methods for sonographically guided core biopsy of the breast. AJR Am J Roentgenol 2003;180:347-51.
16. Fornage BD. Sonographically guided needle biopsy of non-palpable breast lesions. J Clin Ultrasound 1999;27:385-9.
17. Margolin FR, Leung JWT, Jacobs RP, Denny SR. Percutaneous imaging-guided core breast biopsy: 5 year's experience in a community hospital. AJR Am J Roentgenol 2001;177:559-64.
18. Guenin MA. Full disclosure of breast biopsy options. AJR Am J Roentgenol 2002;178:1029-30.